Danielle Brill
Stock Analyst at Raymond James
(0)
# 4140
Out of 5,218 analysts
88
Total ratings
32.69%
Success rate
-5.29%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
uniQure | Upgrades: Strong Buy | 20 52 | 15.35 | 238.76% | 6 | Dec 10, 2024 | |
Tectonic Therapeutic | Initiates Coverage On: Outperform | 65 | 45.42 | 43.11% | 1 | Nov 20, 2024 | |
Denali Therapeutics | Reinstates: Market Perform | n/a | n/a | n/a | 1 | Oct 10, 2024 | |
Biomarin Pharmaceuti... | Reinstates: Outperform | 79 | 66.03 | 19.64% | 1 | Oct 10, 2024 | |
Regenxbio | Reinstates: Outperform | 18 | 8.27 | 117.65% | 1 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Outperform | 155 | 126.68 | 22.36% | 5 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Outperform | 36 | 26.32 | 36.78% | 4 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Outperform | 40 | 32.38 | 23.53% | 7 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Outperform | 150 | 123.57 | 21.39% | 3 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Market Perform | n/a | n/a | n/a | 2 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Market Perform | n/a | n/a | n/a | 2 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Market Perform | n/a | n/a | n/a | 2 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Strong Buy | 605 | 606.64 | -0.27% | 7 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Market Perform | n/a | n/a | n/a | 5 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Outperform | 50 | 40.07 | 24.78% | 2 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Outperform | 51 | 39.09 | 30.47% | 2 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 40 43 | 64.78 | -33.62% | 5 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 9 5 | 0.74 | 575.68% | 5 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | n/a | n/a | n/a | 9 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 5 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 3 | Oct 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 75 50 | n/a | n/a | 5 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Perform | n/a | n/a | n/a | 1 | Aug 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Perform | n/a | n/a | n/a | 1 | Aug 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 3 | Sep 17, 2019 |